Product Information
LAMOTRIGINE 25 MG DISPER TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1473 per EA under NDC 16571078601. Its NADAC has been published 264 times since Sep 15, 2021.
FDA first approved this application on Nov 4, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571078601
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA090401FDA Approved
11/4/2009
TE Code
AB
On Market Since
11/4/2009
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE 25 MG DISPER TAB has been published 264 times since Sep 15, 2021, and over the history we have for it it has declined 54.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1473 per EA |
|---|---|
| All-time high | $0.3228 (Sep 15, 2021) |
| All-time low | $0.1437 (May 22, 2024) |
| 52-week high | $0.1714 |
| 52-week low | $0.1473 |
| Median price | $0.1981 |
| Average price | $0.2061 |
| Largest weekly change | +34.6% (Jan 18, 2023) |
| Weeks tracked | 264 |
| Tracking since | Sep 15, 2021 |
Generic Alternatives
The matcher finds 19 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lamotrigine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE 25 MG DISPER TAB?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE 25 MG DISPER TAB, manufactured by Rising Pharma Holdings Inc., is $0.1473 per EA (NDC 16571078601), effective Sep 30, 2026.
How has the price of LAMOTRIGINE 25 MG DISPER TAB changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE 25 MG DISPER TAB has declined 54.4%. It has been tracked across 264 weekly CMS publications since Sep 15, 2021.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE 25 MG DISPER TAB?
Since Sep 15, 2021, the NADAC for LAMOTRIGINE 25 MG DISPER TAB has ranged from a low of $0.1437 (May 22, 2024) to a high of $0.3228 (Sep 15, 2021), with a median of $0.1981 per EA.
Are there cheaper alternatives to LAMOTRIGINE 25 MG DISPER TAB?
Yes. 19 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 25 MG TABLET, is $0.0268 per EA — about 82% below LAMOTRIGINE 25 MG DISPER TAB.
Who manufactures LAMOTRIGINE 25 MG DISPER TAB?
LAMOTRIGINE 25 MG DISPER TAB (NDC 16571078601) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.